BAMCO Inc
MRVI icon

BAMCO Inc’s Maravai LifeSciences MRVI Stock Holding History

BAMCO Inc’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,203,651
Closed -$12M – 330
2024
Q4 		$12M Buy
2,203,651
+80,000
+4% +$515K 0.03% 225
2024
Q3 		$17.6M Hold
2,123,651
– – 0.05% 213
2024
Q2 		$15.2M Hold
2,123,651
– – 0.04% 222
2024
Q1 		$18.4M Buy
2,123,651
+640,000
+43% +$4.33M 0.05% 215
2023
Q4 		$9.72M Buy
1,483,651
+802,482
+118% +$5.18M 0.03% 235
2023
Q3 		$6.81M Hold
681,169
– – 0.02% 245
2023
Q2 		$8.47M Buy
681,169
+32,169
+5% +$434K 0.02% 240
2023
Q1 		$9.09M Buy
649,000
+133,000
+26% +$1.91M 0.03% 233
2022
Q4 		$7.38M Buy
+516,000
New +$8.12M 0.02% 243

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.03B AUM 19.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return